Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC90 of Ropivacaine with IV Dexamethasone in Axillary Block
NCT03688269Phase 3Completed
- Sponsor
- CHU de Besançon
- Start
- Oct 2018
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in postoperative pain, sponsored by CHU de Besançon. Primary endpoint: Surgical Effectiveness of regional anesthesia at 30min. Started Oct 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03688269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03688269.